What is Neurocrine Biosciences's total assets?

Neurocrine Biosciences (NBIX) reported total assets of $4.91B in Q1 2026.

How has Neurocrine Biosciences's total assets changed year-over-year?

Neurocrine Biosciences's total assets increased by 33.0% year-over-year, from $3.69B to $4.91B.

What is the long-term trend for Neurocrine Biosciences's total assets?

Over 5 years (2020 to 2025), Neurocrine Biosciences's total assets has grown at a 21.7% compound annual growth rate (CAGR), from $1.73B to $4.63B.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Neurocrine Biosciences NBIX Total Assets

Total Assets at other companies

Bristol-Myers SquibbBMY

$86.48B-6.4%

Acadia PharmaceuticalsACAD

$1.61B+41.8%

Crinetics PharmaceuticalsCRNX

$1.4B+2.9%

Solid Biosciences Inc.SLDB

$422.89M+23.0%

MapLight Therapeutics, Inc. MPLT

$418.79M—

BridgeBio PharmaBBIO

$1.37B+55.5%

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$17.3B+29.6%

Enterprise value$17.49B+28.9%

P/E25.9×-12.5×

P/S5.6×+0.3×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's total assets?: Neurocrine Biosciences (NBIX) reported total assets of $4.91B in Q1 2026.
How has Neurocrine Biosciences's total assets changed year-over-year?: Neurocrine Biosciences's total assets increased by 33.0% year-over-year, from $3.69B to $4.91B.
What is the long-term trend for Neurocrine Biosciences's total assets?: Over 5 years (2020 to 2025), Neurocrine Biosciences's total assets has grown at a 21.7% compound annual growth rate (CAGR), from $1.73B to $4.63B.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.